FOXR2 in cancer development: emerging player and therapeutic opportunities

Piao Yang1, Mohsen Sheykhhasan2, Reza Heidari3

  • 1Department of Molecular Genetics, College of Arts and Sciences, The Ohio State University, Columbus, OH, USA.

Oncology Research
|January 27, 2025
PubMed

Insights

Forkhead Box R2 (FOXR2) is an oncogene implicated in many cancers. Understanding FOXR2 dysregulation is key for improving cancer diagnosis, prognosis, and treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer remains a primary cause of global mortality, posing a significant challenge to increasing life expectancy.
  • Forkhead Box R2 (FOXR2), a member of the FOX gene family, is recognized as an oncogene crucial for endoderm-derived organ development.
  • FOXR2 dysregulation is associated with a wide spectrum of malignant tumors, including those of the brain, nervous system, thyroid, and various visceral organs.

Purpose of the Study:

  • To review the mechanisms of FOXR2 dysregulation in oncogenesis.
  • To explore the implications of FOXR2 dysregulation for cancer diagnosis, prognosis, and therapeutic interventions.

Main Methods:

  • Literature review of FOXR2-related pathways and their involvement in oncogenesis.
  • Analysis of studies linking FOXR2 dysregulation to diverse cancer types.
  • Synthesis of current knowledge on FOXR2's role in tumor development and progression.

Main Results:

  • FOXR2 dysregulation is a common feature across numerous cancers, affecting multiple organ systems.
  • FOXR2-related pathways are involved in both tumor initiation and progression.
  • Despite its established role, the clinical utility of FOXR2 in cancer management is largely underexplored.

Conclusions:

  • FOXR2 is a significant oncogene with broad implications in human carcinogenesis.
  • Further research into FOXR2 dysregulation mechanisms could unlock novel diagnostic and therapeutic strategies for various cancers.
  • Targeting FOXR2 pathways may offer potential for improved cancer treatment outcomes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K